On January 3, 2023 Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company leveraging its nanomedicine technology, hydroxyl dendrimers (HDs), to develop a new class of precision medicines, reported that the Company will provide a corporate overview at Biotech Showcase 2023 taking place in San Francisco, California, from January 9-11, 2023 (Press release, Ashvattha Therapeutics, JAN 3, 2023, View Source [SID1234625720]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presenter Jeffrey Cleland, Ph.D., Chairman, Chief Executive Officer and President of Ashvattha, and members of the Ashvattha senior management team will be available for one-on-one meetings throughout the conference. Conference attendees should schedule meetings on the Biotech Showcase website.
Details for the presentation are as follows:
Date: Tuesday, January 10, 2023
Time: 3:15 pm PT
Location: Franciscan-A, Ballroom Level, Hilton San Francisco Union Square